0001103021-20-000018.txt : 20200131 0001103021-20-000018.hdr.sgml : 20200131 20200131174522 ACCESSION NUMBER: 0001103021-20-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200129 FILED AS OF DATE: 20200131 DATE AS OF CHANGE: 20200131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Thomas B CENTRAL INDEX KEY: 0001748462 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31361 FILM NUMBER: 20566275 MAIL ADDRESS: STREET 1: BIODELIVERY SCIENCES INTERNATIONAL, INC. STREET 2: 4131 PARKLAKE AVE SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODELIVERY SCIENCES INTERNATIONAL INC CENTRAL INDEX KEY: 0001103021 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 352089858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 BUSINESS PHONE: 919 582 9050 MAIL ADDRESS: STREET 1: 4131 PARKLAKE AVENUE STREET 2: SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 FORMER COMPANY: FORMER CONFORMED NAME: MAS ACQUISITION XXIII CORP DATE OF NAME CHANGE: 20000111 4 1 wf-form4_158051070415115.xml FORM 4 X0306 4 2020-01-29 0 0001103021 BIODELIVERY SCIENCES INTERNATIONAL INC BDSI 0001748462 Smith Thomas B C/O BIODELIVERY SCIENCES INTL, INC., 4131 PARKLAKE AVE. SUITE 225 RALEIGH NC 27612 0 1 0 0 Chief Medical Officer Stock Options (right to buy) 6.17 2020-01-29 4 A 0 110122 0 A 2030-01-29 Common Stock 110122.0 110122 D Restricted Stock Units 0.0 2020-01-29 4 A 0 22645 0 A 2023-01-29 Common Stock 22645.0 22645 D The exercise price of the stock options issued to the Reporting Person is the volume-weighted average price of the Issuer's common stock for the 30-day period ending on January 28, 2020. The stock options were issued to the Reporting Person on January 29, 2020, pursuant to a grant under the Issuer's 2019 Stock Option and Incentive Plan (the "Plan"). The award is subject to time-based vesting and will vest in equal portions on: (i) January 29, 2021; (ii) January 29, 2022; and (iii) January 29, 2023. The Restricted Stock Units ("RSUs") were issued to the Reporting Person on January 29, 2020, pursuant to a grant under the Plan. The award is subject to time-based vesting and will vest in equal portions on: (i) January 29, 2021; (ii) January 29, 2022; and (iii) January 29, 2023. Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock. /s/ Thomas Smith, MD. 2020-01-31